Eamon Fitzmaurice Civica Rx

Chief Financial Officer Eamon Fitzmaurice joined Civica from Novartis Gene Therapies (previously named AveXis) where he served as Controller, Global Technical Operations shortly after joining the company as Plant Controller in 2018. Prior to Novartis, he was Plant Manager for two years at a Purdue Pharma Oral Solid Dosage facility.

 Eamon previously worked at Novartis Vaccines where he led the U.S./global vaccine finance organization through the sale of Novartis Vaccines to GlaxoSmithKline (GSK), including through the deal closure and integration with CSL. Prior to Novartis Vaccines, he spent 23 years with Merck in Finance and Operations (Production & Operational Excellence). Eamon holds a B. Commerce from University College Cork, Ireland and a CMA from the Chartered Institute of Management Accountants in London, UK.